BACKGROUND: Genome-wide association studies (GWAS) have identified 18 loci associated with serous ovarian cancer (SOC) susceptibility but the biological mechanisms driving these findings remain poorly characterised. Germline cancer risk loci may be enriched for target genes of transcription factors (TFs) critical to somatic tumorigenesis. METHODS: All 615 TF-target sets from the Molecular Signatures Database were evaluated using gene set enrichment analysis (GSEA) and three GWAS for SOC risk: discovery (2196 cases/4396 controls), replication (7035 cases/21 693 controls; independent from discovery), and combined (9627 cases/30 845 controls; including additional individuals). RESULTS: The PAX8-target gene set was ranked 1/615 in the discovery...
Background: Genome-wide association studies (GWAS) have so far reported 12 loci associated with sero...
We sought to identify susceptibility genes for high-grade serous ovarian cancer (HGSOC) by performin...
PAX8 is a lineage-restricted transcription factor that is expressed in epithelial ovarian cancer (EO...
Background: Genome-wide association studies (GWAS) have identified 18 loci associated with serous ov...
Contains fulltext : 170527.pdf (publisher's version ) (Closed access)BACKGROUND: G...
Genome-wide association studies (GWAS) have identified 18 loci associated with serous ovarian cancer...
Genome-wide association studies (GWAS) have identified 18 loci associated with serous ovarian cancer...
Background: Genome-wide association studies (GWAS) have identified 18 loci associated with serous o...
Background: Genome-wide association studies (GWAS) have so far reported 12 loci associated with sero...
BackgroundGenome-wide association studies (GWAS) have so far reported 12 loci associated with serous...
BACKGROUND: Genome-wide association studies (GWAS) have so far reported 12 loci associated with sero...
BackgroundGenome-wide association studies (GWAS) have so far reported 12 loci associated with serous...
Understanding the biology and molecular pathogenesis of ovarian epithelial cancer (EOC) is key to de...
Understanding the biology and molecular pathogenesis of ovarian epithelial cancer (EOC) is key to de...
Understanding the biology and molecular pathogenesis of ovarian epithelial cancer (EOC) is key to de...
Background: Genome-wide association studies (GWAS) have so far reported 12 loci associated with sero...
We sought to identify susceptibility genes for high-grade serous ovarian cancer (HGSOC) by performin...
PAX8 is a lineage-restricted transcription factor that is expressed in epithelial ovarian cancer (EO...
Background: Genome-wide association studies (GWAS) have identified 18 loci associated with serous ov...
Contains fulltext : 170527.pdf (publisher's version ) (Closed access)BACKGROUND: G...
Genome-wide association studies (GWAS) have identified 18 loci associated with serous ovarian cancer...
Genome-wide association studies (GWAS) have identified 18 loci associated with serous ovarian cancer...
Background: Genome-wide association studies (GWAS) have identified 18 loci associated with serous o...
Background: Genome-wide association studies (GWAS) have so far reported 12 loci associated with sero...
BackgroundGenome-wide association studies (GWAS) have so far reported 12 loci associated with serous...
BACKGROUND: Genome-wide association studies (GWAS) have so far reported 12 loci associated with sero...
BackgroundGenome-wide association studies (GWAS) have so far reported 12 loci associated with serous...
Understanding the biology and molecular pathogenesis of ovarian epithelial cancer (EOC) is key to de...
Understanding the biology and molecular pathogenesis of ovarian epithelial cancer (EOC) is key to de...
Understanding the biology and molecular pathogenesis of ovarian epithelial cancer (EOC) is key to de...
Background: Genome-wide association studies (GWAS) have so far reported 12 loci associated with sero...
We sought to identify susceptibility genes for high-grade serous ovarian cancer (HGSOC) by performin...
PAX8 is a lineage-restricted transcription factor that is expressed in epithelial ovarian cancer (EO...